These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27300720)

  • 1. [Complications in the treatment of ocular surface squamous neoplasia with interferon α‑2b in rheumatoid arthritis].
    Torres Suárez E; Pinheiro R; Schrage N
    Ophthalmologe; 2017 Feb; 114(2):155-158. PubMed ID: 27300720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgery Versus Interferon Alpha-2b Treatment Strategies for Ocular Surface Squamous Neoplasia: A Literature-Based Decision Analysis.
    Siedlecki AN; Tapp S; Tosteson AN; Larson RJ; Karp CL; Lietman T; Zegans ME
    Cornea; 2016 May; 35(5):613-8. PubMed ID: 26890663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical chemotherapy for giant ocular surface squamous neoplasia of the conjunctiva and cornea: Is surgery necessary?
    Chaugule SS; Park J; Finger PT
    Indian J Ophthalmol; 2018 Jan; 66(1):55-60. PubMed ID: 29283124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study.
    Galor A; Karp CL; Chhabra S; Barnes S; Alfonso EC
    Br J Ophthalmol; 2010 May; 94(5):551-4. PubMed ID: 19493859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular surface squamous neoplasia in a setting of fungal keratitis: a rare co-occurrence.
    Singh S; Mittal R; Narang P; Mittal V
    Int Ophthalmol; 2019 Mar; 39(3):717-720. PubMed ID: 29423784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Conjunctival squamous cell carcinoma: paradoxical response to interferon eyedrops].
    Mata E; Conesa E; Castro M; Martínez L; de Pablo C; González ML
    Arch Soc Esp Oftalmol; 2014 Jul; 89(7):293-6. PubMed ID: 24269461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitomycin C or interferon as adjuvant therapy to surgery for ocular surface squamous neoplasia: comparative study.
    Blasi MA; Maceroni M; Sammarco MG; Pagliara MM
    Eur J Ophthalmol; 2018 Mar; 28(2):204-209. PubMed ID: 28967069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Fibrinous Anterior Uveitis in a Patient Treated With Topical Interferon-α2b for Ocular Surface Squamous Neoplasia With Uveitis Susceptibility.
    Del-Piñal M; Klein-Burgos C; Martín-Ucero AM; Larrañaga-Cores M; de la Hoz A; López-Vázquez A; Fernández-Gutiérrez E
    Cornea; 2023 May; 42(5):648-650. PubMed ID: 36747320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
    Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
    Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Comparative Study of Topical Interferon α2b Versus Mitomycin C for Primary Ocular Surface Squamous Neoplasia.
    Kusumesh R; Ambastha A; Kumar S; Sinha BP; Imam N
    Cornea; 2017 Mar; 36(3):327-331. PubMed ID: 28079688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.
    Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL
    Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current Practice in the Treatment of Epithelial and Melanocytic Tumours with Interferon-α2b: A Survey of Tertiary Eye Centres in Germany.
    Jiang J; Böhringer D; Auw-Hädrich C; Maier PC; Barth T; Eter N; Fuest M; Geerling G; Heindl LM; Herwig-Carl M; Hintschich C; Hufendiek K; Kampik D; Lieb W; Meller D; Mueller A; Pfeiffer N; Rehak M; Schargus M; Seitz B; Spitzer M; Stahl A; Süsskind D; van Oterendorp C; Wagner FM; Westekemper H; Ziemssen F; Reinhard T
    Klin Monbl Augenheilkd; 2023 Jul; 240(7):891-896. PubMed ID: 36746398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
    Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
    Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.
    Karp CL; Galor A; Chhabra S; Barnes SD; Alfonso EC
    Ophthalmology; 2010 Dec; 117(12):2241-6. PubMed ID: 20619462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.
    Holcombe DJ; Lee GA
    Am J Ophthalmol; 2006 Oct; 142(4):568-71. PubMed ID: 17011846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant interferon alpha 2b for ocular surface squamous neoplasia: An efficient and cost-effective treatment modality in Asian Indian patients.
    Kaliki S; Singh S; Iram S; Tripuraneni D
    Indian J Ophthalmol; 2016 Oct; 64(10):702-709. PubMed ID: 27905329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical chemotherapy for ocular surface squamous neoplasia.
    Nanji AA; Sayyad FE; Karp CL
    Curr Opin Ophthalmol; 2013 Jul; 24(4):336-42. PubMed ID: 23680759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. INF α2b for ocular squamous neoplasia.
    Espandar L; Kassem J
    Ophthalmology; 2011 Jul; 118(7):1485; author reply 1485-6. PubMed ID: 21724051
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
    Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
    Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pegylated interferon alpha 2b for treatment of ocular surface squamous neoplasia: a pilot study.
    Karp CL; Galor A; Lee Y; Yoo SH
    Ocul Immunol Inflamm; 2010 Aug; 18(4):254-60. PubMed ID: 20662655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.